You are here: Industry Insights > compounds

News List

Chinese scientists develop non-hallucinogenic antidepressant compounds FirstWordPharma
January 29, 2022
Chinese scientists designed two new compounds that they say can relieve depression, but do not cause the unwanted effect of hallucination, reported Xinhua.
Anixa Biosciences, MolGenie Find COVID Compounds Effective Against Omicron contractpharma
December 08, 2021
Results of a genomic variant analysis indicate that the compounds in development should be effective against the Omicron variant.
Study suggests some excipients in common drugs are biologically active europeanpharmaceuticalreview
July 27, 2020
Preliminary research has revealed that some excipients used in common medications may interact with important human enzymes and receptors.
Liver, colon cancer cells thwarted by compounds derived from hops worldpharmanews
April 03, 2019
The plant that adds flavor, color and bitterness to beer also produces a primary compound that thwarts cancer cells, and two important derivatives of the compound do as well...
New compounds may prevent spread of malaria pharmaceutical-technology
September 25, 2018
Researchers at Imperial College London have discovered compounds that can potentially prevent malaria parasites from infecting mosquitoes, which could in turn avoid the spread of the disease to humans.
New startup Convelo links old and new compounds to myelin repair in MS fiercepharma
July 30, 2018
With research from Case Western Reserve University, a Cleveland-based startup aims to develop a new class of medicines that help regenerate the insulating myelin sheath around nerve cells, which is degraded in neurological disorders such as multiple scler
Cells of 3 advanced cancers die with drug-like compounds that reverse chemo failure worldpharmanews
January 24, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers - ovarian, prostate and breast.
XW Labs announces exclusive licensing agreement with University of Pittsburgh to develop novel mitoc pharmaasia
March 20, 2017
XW Laboratories announced an exclusive licensing agreement with the University of Pittsburgh to further commercialize a class of novel compounds.